Currently, there are 699.29M common shares owned by the public and among those 697.11M shares have been available to trade.
The company’s stock has a 5-day price change of 2.62% and 12.11% over the past three months. DOC shares are trading 10.81% year to date (YTD), with the 12-month market performance up to 4.98% higher. It has a 12-month low price of $15.24 and touched a high of $22.19 over the same period. DOC has an average intraday trading volume of 4.45 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 2.96%, 8.14%, and 17.00% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Healthpeak Properties Inc. (NYSE: DOC) shares accounts for 94.22% of the company’s 699.29M shares outstanding.
It has a market capitalization of $15.34B and a beta (3y monthly) value of 1.11. The stock’s trailing 12-month PE ratio is 47.22, while the earnings-per-share (ttm) stands at $0.46. The company has a debt-to-equity ratio at 1.04. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.76% over the week and 2.28% over the month.
Earnings per share for the fiscal year are expected to decrease by -40.59%, and -7.41% over the next financial year. EPS should grow at an annualized rate of -12.59% over the next five years, compared to -24.23% over the past 5-year period.
Exane BNP Paribas coverage for the Healthpeak Properties Inc. (DOC) stock in a research note released on April 26, 2024 offered a Outperform rating with a price target of $21. Mizuho was of a view on April 22, 2024 that the stock is Buy, while BofA Securities gave the stock Buy rating on April 01, 2024, issuing a price target of $18- $25. Wells Fargo on their part issued Equal Weight rating on March 25, 2024.
